Markus H Heim
Heim, Markus H.
VIAF ID: 6320155044742972520009 (Personal)
Permalink: http://viaf.org/viaf/6320155044742972520009
Preferred Forms
-
-
100 1 _ ‡a Heim, Markus H.
-
100 0 _ ‡a Markus H Heim
4xx's: Alternate Name Forms (7)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Hepatitis with fibrin-ring granulomas |
![]() |
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors |
![]() |
Hepatozelluläres Karzinom |
![]() |
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models |
![]() |
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection |
![]() |
HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex. |
![]() |
Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression |
![]() |
The IFN-λ Pony Express |
![]() |
IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies |
![]() |
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes |
![]() |
Impact of common risk factors of fibrosis progression in chronic hepatitis C. |
![]() |
Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice. |
![]() |
Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice. |
![]() |
Innate immunity and HCV. |
![]() |
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages |
![]() |
Interferon-gamma receptor signaling is not required in the effector phase of the alloimmune response. |
![]() |
Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. |
![]() |
Interferon lambda 4 can directly activate human CD19+ B cells and CD8+ T cells |
![]() |
Interferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivo |
![]() |
Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C. |
![]() |
Interferons and hepatitis C virus |
![]() ![]() ![]() |
Interleukin 6 is important for survival after partial hepatectomy in mice |
![]() |
An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis B. |
![]() |
Is tumor biopsy necessary? |
![]() |
Isolate-dependent use of claudins for cell entry by hepatitis C virus |
![]() |
The Jak-STAT pathway: specific signal transduction from the cell membrane to the nucleus |
![]() |
LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function |
![]() |
Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells |
![]() |
Liver damage and senescence increases in patients developing hepatocellular carcinoma. |
![]() |
The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota |
![]() |
Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell response |
![]() |
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients |
![]() |
Mapping the Heterogeneity of Histone Modifications on Hepatitis B Virus DNA Using Liver Needle Biopsies Obtained from Chronically Infected Patients |
![]() |
Mechano-modulatory synthetic niches for liver organoid derivation |
![]() |
MicroRNAs 103 and 107 regulate insulin sensitivity |
![]() |
miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis |
![]() |
MRI of Hepatic Adenomatosis: Initial Observations with Gadoxetic Acid Contrast Agent in Three Patients |
![]() |
mTORC2 Promotes Tumorigenesis via Lipid Synthesis |
![]() |
A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients |
![]() |
New insights into HDV-induced innate immunity: MDA5 senses HDV replication. |
![]() |
Nodular regenerative hyperplasia in a patient with generalized essential telangiectasia: Endotheliopathy as a causal factor |
![]() |
Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice |
![]() |
Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index |
![]() |
Nucleotide sequence of rabbit NAT2 encoding polymorphic liver arylamine N-acetyltransferase (NAT). |
![]() |
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies |
![]() |
Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activation |
![]() |
Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation. |
![]() |
Peroxisomal β-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis |
![]() |
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib. |
![]() |
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication |
![]() |
Polymerase chain reaction and its potential as a pharmacokinetic tool |
![]() |
Predicting debrisoquine phenotype |
![]() |
The protein histidine phosphatase LHPP is a tumour suppressor. |
![]() |
Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53. |
![]() |
Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patient |
![]() |
Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A protease |
![]() |
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin |
![]() |
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes |
![]() |
RIG-I: an essential regulator of virus-induced interferon production |
![]() |
The RNA-binding protein vigilin regulates VLDL secretion through modulation of Apob mRNA translation |
![]() |
The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size. |
![]() |
S-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponse |
![]() |
Sequential induction of type I and II interferons mediates a long-lasting gene induction in the liver in response to a novel toll-like receptor 9 agonist |
![]() |
SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules |
![]() |
Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls |
![]() |
SOCS1 is an inducible negative regulator of IFN lambda induced gene expression in vivo |
![]() |
Specific activation of AP-1 but not Stat3 in regenerating liver in mice |
![]() |
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. |
![]() |
Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization |
![]() |
Symptomatic Hepatocellular Liver Injury With Hyperbilirubinemia in Two Patients Treated With Rivaroxaban |
![]() |
A systematic review and meta-analysis of HCV clearance |
![]() |
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study |
![]() |
Ultrasound surveillance for hepatocellular carcinoma: real-life performance in a hepatology outpatient clinic |
![]() |
Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma |
![]() |
Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1. |
![]() |
Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C. |
![]() |
Vitamin D receptor and Jak-STAT signaling crosstalk results in calcitriol-mediated increase of hepatocellular response to IFN-α. |
![]() |
YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors. |
![]() |